Immune and environmental determinants of diabetic bone fragility: bone microenvironment remodeling, organ crosstalk, and therapeutic perspectives
Diabetic bone disease is increasingly recognized as a complication in which fracture risk exceeds what bone mineral density (BMD) predicts: in type 2 diabetes mellitus (T2DM) despite preserved or elevated BMD, and in type 1 diabetes mellitus (T1DM) beyond its BMD deficit. We re-examine this problem through the immune-m...